Taye, Behailu
Melkamu, Roma
Tajebe, Fitsumbrhan
Ibarra-Meneses, Ana Victoria
Adane, Desalegn
Atnafu, Saba
Adem, Mohammed
Adane, Gashaw
Kassa, Mekibib
Asres, Mezgebu Silamsaw
van Griensven, Johan
van Henten, Saskia
Pareyn, Myrthe
Article History
Received: 1 May 2024
Accepted: 3 September 2024
First Online: 15 October 2024
Declarations
:
: The study was approved by the ethical and review committee of the School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar (SBMLS/288), the Institutional Review Board of the Institute of Tropical Medicine Antwerp (ref. 1584/22) and the Ethics Committee of the Antwerp University Hospital (ref. 3511). Samples were only collected from patients who previously provided written informed consent for long-term storage and secondary use of their samples for leishmaniasis research (ClinicalTrials.gov identifier: NCT03837431).
: Not applicable.
: The authors declare that they have no competing interests.